STRAVENCON
LIVE

Serial Number

79097290

Owner

Stravencon Limited

Filing Date

Feb 14, 2011

Add to watchlist:

No watchlists yet
View on USPTO

STRAVENCON Trademark

Serial Number: 79097290 • Registration: 4103838

STRAVENCON is a trademark filed by Stravencon Limited on February 14, 2011. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 39 (Transportation & Storage), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Stravencon Limited

Landmark House, 17 Hanover Sq., Mayfair

Entity Type: 16

Trademark Details

Filing Date

February 14, 2011

Registration Date

February 28, 2012

Published for Opposition

December 13, 2011

Cancellation Date

February 14, 2021

Goods & Services

Surgical, medical, veterinary and dental devices, apparatus and instruments, namely, drug delivery systems, knives for surgical use, lasers for surgical and medical use, catheters for surgical use, and surgical and medical apparatus and instruments for use in general surgery; artificial limbs, eyes and teeth; orthopedic articles, namely, orthopedic apparatus and instruments for diagnostic and therapeutic use; suture materials

Warehousing services, namely, storage, distribution, pick-up, packing, and shipping of pharmaceutical products and medical apparatus, instruments and devices; information, advisory and consultancy services relating to the aforesaid

Pharmaceutical preparations, namely, anti-bacterial, anti-diabetic, anti-viral, anti-sickness, anti-infective and cardiovascular treatment pharmaceuticals, anti-allergic pharmaceutical preparations, pharmaceutical preparations for the treatment of infectious diseases and disorders of the central nervous system, pharmaceutical preparations for hormonal deficiencies, erectile dysfunction and reproductive dysfunction, pharmaceutical preparations for use in oncology; veterinary preparations, namely, therapeutic anti-infective, anti-bacterial, anti-sickness and anti-allergic pharmaceuticals and therapeutic veterinary preparations, namely, pharmaceuticals for the treatment of infectious diseases, hormonal deficiencies and for use in oncology, all for livestock and domestic animals; sanitary preparations for medical purposes; dietetic foods adapted for medical use; material for stopping teeth; vaccines

Marketing services, namely, promoting or advertising the goods and services of others; marketing support services, namely, advertising and marketing of pharmaceutical and diagnostic preparations, therapeutics, medical apparatus, instruments and devices of third parties to enable them to be accepted and sold for worldwide distribution; creation of marketing partnerships between companies, namely, cooperative advertising and marketing of pharmaceutical companies as partners and their intellectual property licenses for the regulatory acceptance and sale of pharmaceuticals, medical apparatus, instruments and devices for worldwide distribution; advertising agencies; business development; consultation in the field of sales promotion services for business purposes; sourcing in the nature of procurement, namely, purchasing for others pharmaceutical products and medical apparatus, instruments and devices from third parties for worldwide distribution; import and export agencies; business auditing and preparation of business reports in the field of pharmaceutical products, and medical apparatus, instruments and device, for the purpose of regulatory guidance; executive recruiting services of management staff and personnel for pharmaceuticals and life sciences companies; business advisory and management services relating to company acquisitions and identifying and negotiating company acquisitions for third parties; business management and advisory services relating to obtaining marketing authorisations from relevant governing authorities in respect of pharmaceutical products, medical apparatus, instruments and devices; computerised database management; compilation and systemization of information into computer databases; commercial information agencies featuring a computer database; all of the aforesaid also provided online via the Internet or other interactive electronic platforms; information, advisory and consultancy services relating to all of the aforesaid

Licensing of pharmaceutical products; licensing of intellectual property for research and development purposes; licensing of intellectual property relating to pharmaceutical products, medical apparatus, instruments and devices; providing regulatory compliance information in the field of pharmaceuticals, medical devices, apparatus and instruments; information, advisory and consultancy services relating to all of the aforesaid

Filing History

WITHDRAWAL OF ATTORNEY GRANTED
Nov 11, 2021 WOAG
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Nov 11, 2021 WOAR
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 2, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 2, 2021 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Nov 30, 2019 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 28, 2019 INTS
INVALIDATION PROCESSED
Jun 28, 2019 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jun 5, 2019 INTR
CANCELLED SECTION 71
Oct 5, 2018 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 28, 2017 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 20, 2016 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 26, 2015 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 14, 2014 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 13, 2013 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 15, 2012 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 19, 2012 FICS
FINAL DISPOSITION PROCESSED
Oct 19, 2012 FIMP
NOTIFICATION PROCESSED BY IB
Jul 1, 2012 GPNX
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 28, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 28, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 13, 2011 NPUB
PUBLISHED FOR OPPOSITION
Dec 13, 2011 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 23, 2011 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 23, 2011 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 23, 2011 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 4, 2011 PREV
ASSIGNED TO LIE
Nov 4, 2011 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 14, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 14, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 14, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 14, 2011 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 19, 2011 TROA
REFUSAL PROCESSED BY IB
Jul 4, 2011 RFNT
APPLICATION FILING RECEIPT MAILED
Jun 14, 2011 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 13, 2011 RFCS
REFUSAL PROCESSED BY MPU
Jun 13, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 12, 2011 RFCR
NON-FINAL ACTION WRITTEN
Jun 11, 2011 CNRT
ASSIGNED TO EXAMINER
Jun 10, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 10, 2011 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 9, 2011 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 9, 2011 REPR